Precision Biosciences DTIL
NASDAQ DTIL
$6.31 -0.02 (-0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Cash & Current Investments (2018 - 2026)

Updated

Precision Biosciences (DTIL) posted Cash & Current Investments of $87.55 million for fiscal Q2 2026 (quarter ended Jun 30, 2026), up 40.7% from $62.24 million a year earlier but down 13.5% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025 (ended Dec 31, 2025), Precision Biosciences' Cash & Current Investments came in at $115.59 million, up 33.9% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 5.2% (FY2020 to FY2025).
  • In prior fiscal years, Precision Biosciences' Cash & Current Investments was $86.31 million in FY2024 (-26.0%), $116.68 million in FY2023 (-38.5%), $189.58 million in FY2022 (+32.0%) and $143.66 million in FY2021 (+60.0%).
  • Quarterly Cash & Current Investments has run from a low of $44.87 million in fiscal Q3 2025 to a high of $212.05 million in fiscal Q3 2022 over five years.
  • On a year-over-year basis, Cash & Current Investments has increased in each of the last three quarters, with an average decline of 10.9% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was fiscal Q4 2021, with growth of 60.0%; the weakest was fiscal Q3 2025, with a decline of 55.7%.
  • According to Business Quant data, Cash & Current Investments for the three prior fiscal quarters was $101.18 million (Q1 2026), $115.59 million (Q4 2025) and $44.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Precision Biosciences 166.80 Mn -182.39 Mn - 87.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 87.55 Mn
Mar 31, 2026 101.18 Mn
Dec 31, 2025 115.59 Mn
Sep 30, 2025 44.87 Mn
Jun 30, 2025 62.24 Mn
Mar 31, 2025 77.22 Mn
Dec 31, 2024 86.31 Mn
Sep 30, 2024 101.20 Mn
Jun 30, 2024 123.57 Mn
Mar 31, 2024 137.77 Mn
Dec 31, 2023 116.68 Mn
Sep 30, 2023 122.23 Mn
Jun 30, 2023 137.79 Mn
Mar 31, 2023 158.13 Mn
Dec 31, 2022 189.58 Mn
Sep 30, 2022 212.05 Mn
Jun 30, 2022 184.14 Mn
Mar 31, 2022 116.22 Mn
Dec 31, 2021 143.66 Mn
Sep 30, 2021 160.47 Mn
API Access

Precision Biosciences Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DTIL&period=max&api_key=YOUR_API_KEY